Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis

M. Pardeo; J. Wang; N. Ruperto; E. Alexeeva; V. Chasnyk; R. Schneider; G. Horneff; H.-I. Huppertz; K. Minden; K. Onel; L. Zemel; A. Martin; I. Koné-Paut; A. Siamopoulou-Mavridou; C.A. Silva; B. Porter-Brown; K.N. Bharucha; H.I. Brunner; F. De Benedetti; for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG)

doi:10.3899/jrheum.180795

Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis

M. Pardeo, J. Wang, N. Ruperto, E. Alexeeva, V. Chasnyk, R. Schneider, G. Horneff, H.-I. Huppertz, K. Minden, K. Onel, L. Zemel, A. Martin, I. Koné-Paut, A. Siamopoulou-Mavridou, C.A. Silva, B. Porter-Brown, K.N. Bharucha, H.I. Brunner, F. De Benedetti, for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG)

Istituto "Giannina Gaslini"

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1117-1126
Number of pages	10
Journal	Journal of Rheumatology
Volume	46
Issue number	9
DOIs	https://doi.org/10.3899/jrheum.180795
Publication status	Published - 2019

Access to Document

10.3899/jrheum.180795

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071719321&doi=10.3899%2fjrheum.180795&partnerID=40&md5=5f764e0b9f58c7410eb1f7048e80dfb5

Cite this

Pardeo, M., Wang, J., Ruperto, N., Alexeeva, E., Chasnyk, V., Schneider, R., Horneff, G., Huppertz, H-I., Minden, K., Onel, K., Zemel, L., Martin, A., Koné-Paut, I., Siamopoulou-Mavridou, A., Silva, C. A., Porter-Brown, B., Bharucha, K. N., Brunner, H. I., De Benedetti, F., & (PRCSG), F. T. P. R. I. T. O. PRINTO. A. T. P. R. C. S. G. (2019). Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis. Journal of Rheumatology, 46(9), 1117-1126. https://doi.org/10.3899/jrheum.180795

Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis. / Pardeo, M.; Wang, J.; Ruperto, N.; Alexeeva, E.; Chasnyk, V.; Schneider, R.; Horneff, G.; Huppertz, H.-I.; Minden, K.; Onel, K.; Zemel, L.; Martin, A.; Koné-Paut, I.; Siamopoulou-Mavridou, A.; Silva, C.A.; Porter-Brown, B.; Bharucha, K.N.; Brunner, H.I.; De Benedetti, F.; (PRCSG), for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group.

In: Journal of Rheumatology, Vol. 46, No. 9, 2019, p. 1117-1126.

Research output: Contribution to journal › Article › peer-review

Pardeo, M, Wang, J, Ruperto, N, Alexeeva, E, Chasnyk, V, Schneider, R, Horneff, G, Huppertz, H-I, Minden, K, Onel, K, Zemel, L, Martin, A, Koné-Paut, I, Siamopoulou-Mavridou, A, Silva, CA, Porter-Brown, B, Bharucha, KN, Brunner, HI, De Benedetti, F & (PRCSG), FTPRITOPRINTOATPRCSG 2019, 'Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis', Journal of Rheumatology, vol. 46, no. 9, pp. 1117-1126. https://doi.org/10.3899/jrheum.180795

Pardeo, M. ; Wang, J. ; Ruperto, N. ; Alexeeva, E. ; Chasnyk, V. ; Schneider, R. ; Horneff, G. ; Huppertz, H.-I. ; Minden, K. ; Onel, K. ; Zemel, L. ; Martin, A. ; Koné-Paut, I. ; Siamopoulou-Mavridou, A. ; Silva, C.A. ; Porter-Brown, B. ; Bharucha, K.N. ; Brunner, H.I. ; De Benedetti, F. ; (PRCSG), for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group. / Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis. In: Journal of Rheumatology. 2019 ; Vol. 46, No. 9. pp. 1117-1126.

@article{5767f027f3e543a3bad41c9e4fb71f07,

title = "Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis",

author = "M. Pardeo and J. Wang and N. Ruperto and E. Alexeeva and V. Chasnyk and R. Schneider and G. Horneff and H.-I. Huppertz and K. Minden and K. Onel and L. Zemel and A. Martin and I. Kon{\'e}-Paut and A. Siamopoulou-Mavridou and C.A. Silva and B. Porter-Brown and K.N. Bharucha and H.I. Brunner and {De Benedetti}, F. and (PRCSG), {for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group}",

note = "Export Date: 7 February 2020",

year = "2019",

doi = "10.3899/jrheum.180795",

language = "English",

volume = "46",

pages = "1117--1126",

journal = "Journal of Rheumatology",

issn = "0315-162X",

publisher = "Journal of Rheumatology",

number = "9",

}

TY - JOUR

T1 - Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis

AU - Pardeo, M.

AU - Wang, J.

AU - Ruperto, N.

AU - Alexeeva, E.

AU - Chasnyk, V.

AU - Schneider, R.

AU - Horneff, G.

AU - Huppertz, H.-I.

AU - Minden, K.

AU - Onel, K.

AU - Zemel, L.

AU - Martin, A.

AU - Koné-Paut, I.

AU - Siamopoulou-Mavridou, A.

AU - Silva, C.A.

AU - Porter-Brown, B.

AU - Bharucha, K.N.

AU - Brunner, H.I.

AU - De Benedetti, F.

AU - (PRCSG), for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group

N1 - Export Date: 7 February 2020

PY - 2019

Y1 - 2019

U2 - 10.3899/jrheum.180795

DO - 10.3899/jrheum.180795

M3 - Article

VL - 46

SP - 1117

EP - 1126

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 9

ER -